- June 10, 2016Read more
On June 3, 2016, our CEO, Dr. Haas, was invited to join other CEO’s and Chirlane McCray, NYC Mayor De Blasio’s wife, in a dynamic discussion that covered several critically important issues, including the need to address mental health in complex business environments.
Cohen Veterans Bioscience President & CEO Magali Haas Speaks at the Milken Institute Global Conference: Bringing 21st Century Medicine to America’s VeteransMay 20, 2016Read more
Cohen Veterans Bioscience is investing in research on a global scale that will speed the discovery of first generation diagnostics, treatments, and cures by improving the scientific understanding of the basic biological mechanisms that set the stage for these conditions
- March 1, 2016Read more
The 2-day workshop brought together 25 scientists who are directly involved in PTSD research or have key experience in this field, with the goal of addressing challenges in PTSD translational science in order to establish a preclinical roadmap to help advance new therapeutics.
- January 18, 2016Read more
Cohen Veterans Bioscience is pleased to participate in Arrowhead Publisher’s 6th Annual Traumatic Brain Injury Conference coming back to Washington, DC on May 11-12th 2016. This conference brings together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury.
- December 16, 2015Read more
Cohen Veterans Bioscience held its first Preclinical PTSD Working Group meeting in Hollywood, Florida on December 5, 2015. This event was co-chaired by Dr. Kerry Ressler, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, and Dr. Magali Haas, CEO of Cohen Veterans Bioscience. The Cohen Veterans Bioscience Preclinical Working Group is designed to bring together world-leading clinical researchers and preclinical scientists from academia and industry with the goal of informing Cohen Veterans Bioscience’s preclinical development strategy.